- Our Work
- Get Involved
Mandar Paradkar, MBBS, DCH, MPH
Dr. Paradkar is Study Coordinator at the Byramjee Jeejeebhoy Government Medical College Clinical Research Site (BJGMC-CRS) in Pune, India. He coordinates the Regional, Prospective, Observational Research in Tuberculosis (RePORT India) studies at the site including: Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPh) and its several biomarker substudies, the Common protocol, RICC Pediatric Transcriptomic study (Co-PI); the TBM Kids clinical trial and its substudy to establish a CSF biorepository for children with suspected meningoencephalitis. He is also coordinating the upcoming studies Genome Wide Analysis Study (RO1, GWAS) and the UNITAID BENEFIT Kids/CATALYST study. He is a pediatrician by training and successfully completed the full time Master of Public Health degree through Cardiff University, UK, under the prestigious Commonwealth Scholarship Program in November, 2015. He rejoined the site in role of study coordinator December 2015.
In his current role, he coordinates the study activities for adult and pediatric TB study teams at the site. These activities involve regulatory documentation and reporting to the regulatory bodies at the site, recruitment of participants, ensuring the conduct of study procedures are in accordance with the study protocol, staff training, QC procedures, and regular communication with the CRS leadership, study laboratories, BJGMC faculty, local authorities for National TB control programme (RNTCP) and the protocol teams on relevant subjects. His research interests are clinical epidemiology of pediatric TB, TBM, HIV-TB co-infection and aims for research and publications in this subject area.
He completed his medical education in 2007 followed by pediatric post-graduation in 2009, and he worked as a pediatric intensive care registrar at Deenanath Mangeshkar Hospital, a tertiary care hospital in Pune, for a short tenure. He then joined the BJMC-CRS in 2011 and worked for four years as a pediatric research clinician for various HIV studies, including the PROMISE study under NIH’s IMPAACT trial network. He also assisted in adult cryptococcal meningitis study under NIH’s ACTG trial network.
Dr. Paradkar was selected as the New Investigator awardee for year 2011-12 by the IMPAACT network and received mentorship during the award year by Dr. Charles Mitchel (US based IMPAACT investigator). This award included participation on a network protocol development team (Dose finding, safety, and tolerance study of Raltegravir containing antiretroviral therapy in children), participation on the IMPAACT HIV complications scientific committee, and a grant award for research or training purposes. Dr. Paradkar completed the Clinical Vaccine Trials and Good Clinical Practice certificate course from Johns Hopkins University, attended the annual IMPAACT network meetings in Washington, DC, in 2011 and 2012.